Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grignani

Showing results (521-530 of 688) with videos related to

Pageof 69
Sort By:
Journal for Immunotherapy of Cancer|April 10, 2020
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access programJohn W Walker, Celeste Lebbé, Giovanni Grignani, et al.
BMC Cancer|April 22, 2016
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneE Palmerini, R L Jones, E Marchesi, et al.
Genes|June 27, 2024
Evaluation of a New DNA Extraction Method on Challenging Bone Samples Recovered from a WWII Mass GraveBarbara Di Stefano, Irena Zupanič Pajnič, Monica Concato, et al.
Ecology and Evolution|June 16, 2017
Towards the co-ordination of terrestrial ecosystem protocols across European research infrastructuresLes G Firbank, Chiara Bertora, David Blankman, et al.
The Lancet. Haematology|December 22, 2015
Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 studyRosangela Invernizzi, Federica Quaglia, Catherine Klersy, et al.
Molecular Cancer|December 17, 2009
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathwaysYmera Pignochino, Giovanni Grignani, Giuliana Cavalloni, et al.
Ecancermedicalscience|October 6, 2015
miRNAs and resistance to EGFR-TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistanceBiagio Ricciuti, Carmen Mecca, Matteo Cenci, et al.
Blood|February 14, 2012
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expressionGiuseppe Zardo, Alberto Ciolfi, Laura Vian, et al.
Oncoimmunology|May 4, 2018
CD44v6 as innovative sarcoma target for CAR-redirected CIK cellsV Leuci, G M Casucci, G Grignani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2013
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical modelsYmera Pignochino, Carmine Dell'Aglio, Marco Basiricò, et al.
Pageof 69

Showing results (521-530 of 688) with videos related to

Sort By:
Pageof 69
Journal for Immunotherapy of Cancer|April 10, 2020
Efficacy and safety of avelumab treatment in patients with metastatic Merkel cell carcinoma: experience from a global expanded access programJohn W Walker, Celeste Lebbé, Giovanni Grignani, et al.
BMC Cancer|April 22, 2016
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneE Palmerini, R L Jones, E Marchesi, et al.
Genes|June 27, 2024
Evaluation of a New DNA Extraction Method on Challenging Bone Samples Recovered from a WWII Mass GraveBarbara Di Stefano, Irena Zupanič Pajnič, Monica Concato, et al.
Ecology and Evolution|June 16, 2017
Towards the co-ordination of terrestrial ecosystem protocols across European research infrastructuresLes G Firbank, Chiara Bertora, David Blankman, et al.
The Lancet. Haematology|December 22, 2015
Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 studyRosangela Invernizzi, Federica Quaglia, Catherine Klersy, et al.
Molecular Cancer|December 17, 2009
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathwaysYmera Pignochino, Giovanni Grignani, Giuliana Cavalloni, et al.
Ecancermedicalscience|October 6, 2015
miRNAs and resistance to EGFR-TKIs in EGFR-mutant non-small cell lung cancer: beyond 'traditional mechanisms' of resistanceBiagio Ricciuti, Carmen Mecca, Matteo Cenci, et al.
Blood|February 14, 2012
Polycombs and microRNA-223 regulate human granulopoiesis by transcriptional control of target gene expressionGiuseppe Zardo, Alberto Ciolfi, Laura Vian, et al.
Oncoimmunology|May 4, 2018
CD44v6 as innovative sarcoma target for CAR-redirected CIK cellsV Leuci, G M Casucci, G Grignani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2013
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical modelsYmera Pignochino, Carmine Dell'Aglio, Marco Basiricò, et al.
Pageof 69